CVS pulls phenylephrine amid legal woes
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
Drug retailers, makers face https://seekingalpha.com/news/4022283-drug-retailers-makers-face-mounting-litigation-over-decongestant-products?source=wsb_podcast:cvs_pulls_phenylephrine_amid_legal_woes over decongestant products. (00:25) Toyota (TM) works out https://seekingalpha.com/news/4022198-toyota-works-out-deal-with-tesla-to-adopt-nacs-charging-standard?source=wsb_podcast:cvs_pulls_phenylephrine_amid_legal_woes with Tesla (TSLA) to adopt NACS charging standard. (02:27) Jazz Pharmaceuticals (JAZZ) exploring https://seekingalpha.com/news/4022284-jazz-pharmaceuticals-exploring-strategic-options-including-sale-bloomberg?source=wsb_podcast:cvs_pulls_phenylephrine_amid_legal_woes, including sale...
show moreEpisode transcripts seekingalpha.com/wsb.
Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.
Show links:
Biggest stock movers today: SolarEdge Technologies, Intuitive Surgical and more
China to restrict exports of key EV battery material graphite
Microsoft paid top boss Nadella $48.5M in fiscal 2023
Starbucks sues Workers United union over damaging social media post
Market investors aren’t as worried about the state of the world as they should be - Paul Singer
Information
| Author | Seeking Alpha |
| Website | seekingalpha.com |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
